MetLife Investment Management’s RB Global RBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Sell
89,692
-2,157
-2% -$227K 0.05% 376
2026
Q1
$8.8M Buy
91,849
+577
+0.6% +$61.2K 0.04% 398
2025
Q4
$9.39M Sell
91,272
-4,653
-5% -$473K 0.05% 377
2025
Q3
$10.4M Sell
95,925
-4,314
-4% -$484K 0.05% 350
2025
Q2
$10.6M Sell
100,239
-2,143
-2% -$220K 0.06% 299
2025
Q1
$10.3M Sell
102,382
-1,552
-1% -$148K 0.06% 321
2024
Q4
$9.38M Buy
103,934
+8,723
+9% +$780K 0.05% 279
2024
Q3
$7.66M Sell
95,211
-1,521
-2% -$123K 0.04% 338
2024
Q2
$7.39M Buy
96,732
+87,449
+942% +$6.55M 0.04% 322
2024
Q1
$707K Buy
9,283
+28
+0.3% +$1.96K ﹤0.01% 1491
2023
Q4
$619K Sell
9,255
-132
-1% -$8.48K ﹤0.01% 1566
2023
Q3
$587K Buy
9,387
+5
+0.1% +$308 ﹤0.01% 1536
2023
Q2
$563K Buy
9,382
+5,604
+148% +$316K ﹤0.01% 1622
2023
Q1
$213K Buy
+3,778
New +$223K ﹤0.01% 2185

Other funds holding RBA

MetLife Investment Management's RBA Position: Q2 2026 in Review

MetLife Investment Management reduced its RB Global (RBA) stake by 2.3% in Q2 2026, selling an estimated $227K and leaving 89,692 shares worth $10.4M. The position accounts for 0.05% of the portfolio, ranked #376.

MetLife Investment Management first reported a position in RBA in Q1 2023 and has held it in 14 quarters since. The position peaked at $10.6M in Q2 2025. 559 funds tracked by Wall St. Rank hold RBA as of Q2 2026.

  • MetLife Investment Management held 89,692 shares of RB Global worth $10.4M as of Q2 2026.
  • MetLife Investment Management sold 2,157 RB Global shares in Q2 2026, an estimated $227K.
  • RB Global made up 0.05% of MetLife Investment Management's portfolio in Q2 2026, its #376 holding.
  • MetLife Investment Management first reported a position in RB Global in Q1 2023 and has held it in 14 quarters since.
  • MetLife Investment Management's RB Global position peaked at $10.6M in Q2 2025.
  • 559 funds tracked by Wall St. Rank held RB Global as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.